Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Delcath Systems Inc (DCTH)  
$7.78 0.07 (0.89%) as of 4:30 Fri 5/24


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 15,280,000
Market Cap: 118.88(M)
Last Volume: 1,505,916 Avg Vol: 1,501,790
52 Week Range: $2.25 - $8.09
Level I Sector: Industrials
Level II Sector: Diversified Services
Level III Sector: Research Services

Member Indexes:

    NASDAQ COMPOSITE

Rankings:

     
Insider 3 Months    : 8.6
Insider 6 Months    : 11.3
Insider 3/6 Months : 20.1
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Delcath Systems is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Co.'s primary product candidate, the HEPZATO™ KIT (melphalan hydrochloride for injection/hepatic delivery system) (HEPZATO), is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In Europe, Co.'s commercial product is a stand-alone medical device having the same device components as the HEZPATO but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT® Hepatic Delivery System for Melphalan.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 53,764 127,764 382,819 547,434
Total Buy Value $200,002 $419,962 $1,081,809 $1,686,989
Total People Bought 2 4 8 9
Total Buy Transactions 2 4 10 15
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 118
  Page 5 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Philips Laura A Director   –       •      –    2015-07-22 4 B $0.49 $35,376 D/D 71,642 114,288 2.39     -
   Rueckert William Dodge Director   –       •      –    2015-07-22 4 B $0.48 $9,580 D/D 20,000 40,000 2.39     -
   Stoll Roger G Phd Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 57,500 79,145     -
   Keck Barbra Senior VP, Finance   •       –      –    2015-06-10 4 A $0.00 $0 D/D 73,125 86,475     -
   Koplewicz Harold S Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 20,000 45,052     -
   Taglietti Marco Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 20,000 20,000     -
   Langer Dennis Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 20,000 20,000     -
   Rueckert William Dodge Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 20,000 20,000     -
   Purpura John See Remarks   •       –      –    2015-06-10 4 A $0.00 $0 D/D 100,500 124,205     -
   Philips Laura A Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 20,000 42,646     -
   Simpson Jennifer K. President & CEO   •       –      –    2015-06-10 4 A $0.00 $0 D/D 201,375 219,337     -
   Stoll Roger G Phd Director   –       •      –    2014-07-07 4 A $0.00 $0 D/D 9,616 21,645     -
   Philips Laura A Director   –       •      –    2014-07-07 4 A $0.00 $0 D/D 9,616 22,646     -
   Watson Douglas G Director   –       •      –    2014-07-07 4 A $0.00 $0 D/D 9,615 136,664     -
   Koplewicz Harold S Director   –       •      –    2014-07-07 4 A $0.00 $0 D/D 9,616 25,052     -
   Brege Laura Director   –       •      –    2014-07-07 4 A $0.00 $0 D/D 9,616 11,678     -
   Leung Gabriel Director   –       •      –    2014-07-07 4 A $0.00 $0 D/D 14,424 21,485     -
   Konidaris Tasos Director   –       •      –    2014-07-07 4 A $0.00 $0 D/D 9,616 11,678     -

  118 Records found
  1  2  3  4  5    
  Page 5 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed